• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Vatera Healthcare Partners

edit

Vatera Healthcare Partners is a venture capital firm specializing in investment in biopharmaceutical firms and products and in companies that develop innovative products for unmet and underserved medical needs. The firm was founded in 2007 and is based in New York, New York.

Recent Milestones

edit

• 
  Vatera Healthcare Partners invested in Rib-X Pharmaceuticals. (11/29/12)
  Posted 11/29/12 at 10:22pm via masshightech.com
• 
  Vatera Healthcare Partners invested in Pearl Therapeutics. (11/13/12)
  Posted 11/14/12 at 7:01pm via finsmes.com
• 
  Vatera Healthcare Partners invested in ImmusanT. (12/13/11)
  Posted 12/13/11 at 8:51pm via prnewswire.com
• 
  Vatera Healthcare Partners invested in Pearl Therapeutics. (10/19/10)
  Posted 10/19/10 at 8:59pm via fiercebiotech.com

Investments

Videos

Sources

1. Rib-X closes first tranche of $67.5M financing (masshightech.com) [edit]
2. Pearl Therapeutics Raises $65M in Series D Financing (finsmes.com) [edit]
3. ImmusanT Raises $20 Million in Series A Financing to Advance Immunotherapeutic and Diagnostic for Celiac Disease (prnewswire.com) [edit]
4. Pearl lands $69M Series C for mid-stage COPD program (fiercebiotech.com) [edit]